Filing Details
- Accession Number:
- 0001209191-20-008870
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-12 17:14:55
- Reporting Period:
- 2020-02-10
- Accepted Time:
- 2020-02-12 17:14:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1334365 | Yuchun Lee | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-10 | 1,181 | $57.27 | 3,056 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-10 | 120 | $240.04 | 2,936 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-10 | 360 | $241.61 | 2,576 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-10 | 360 | $242.86 | 2,216 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-10 | 229 | $243.55 | 1,987 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-10 | 112 | $244.79 | 1,875 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2020-02-10 | 1,181 | $0.00 | 1,181 | $57.27 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,125 | 2022-09-13 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $240.04 (range $239.59 to $240.49).
- Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $241.61 (range $241.26 to $241.87).
- Open market sales reported on this line occurred at a weighted average price of $242.86 (range $242.37 to $243.36).
- Open market sales reported on this line occurred at a weighted average price of $243.55 (range $243.46 to $243.72).
- Open market sales reported on this line occurred at a weighted average price of $244.79 (range $244.78 to $244.84).
- Fully vested.
Billionaire Hedge Funds
